Those with a severe allergy to peanuts can eat foods containing peanuts within two weeks of receiving an antibody therapy, according to new study. According to a research published in the journal JCI Insight, the novel medication has no adverse effects and may be used to treat food allergies quickly, safely, and effectively. As many as 32 million people in the United States have food allergies. To yet, oral immunotherapy is the sole treatment option. While it may take 6 months or a year for this therapy to show results, people may experience serious health problems while undergoing it.
A single dose of peanut-allergy immunoglobulin was administered to 14 adults with a severe sensitivity to the legume. In addition, a placebo injection was administered to a different group of individuals with legume allergy. Study participants who received antibody injections gained tolerance to ingest 275-mg peanut proteins, which is the same amount found in one peanut, in just 15 days, under the supervision of doctors, according to the findings. To the contrary, no resistance to proteins was developed in any of the five volunteers who received placebos. The 7 volunteers from the first group and all of the volunteers in the placebo group were retested for this study. Four of the first group’s subjects showed protein tolerance, but none of the second group’s participants could.
In a similar vein, a recent study found that children under the age of 18 who were provided the option of breastfeeding and who were delivered vaginally had lower rates of asthma and allergy symptoms. Researchers in this study gathered data on the eating habits and delivery methods of 158,422 children.